Eksplorativ” head to head ” - sammenligning med proteasehæmmer (PI) hos PI- naive patienter (forsøg TMC125- C227) TMC125- C227 var et eksplorativt, randomiseret, aktivt kontrolleret åbent forsøg, som havde til formål at undersøge effekten og sikkerheden af INTELENCE i et behandlingsregime, som ikke er godkendt under den aktuelle indikation.
Exploratory head to head comparison with protease inhibitor in protease inhibitor naïve patients (trial TMC125-C227) TMC125-C227 was an exploratory, randomised, active-controlled open-label trial, which investigated the efficacy and safety of INTELENCE in a treatment regimen, which is not approved under the current indication.